Asset management firms have been actively adjusting their positions in Thermo Fisher Scientific Inc. (TMO). UniSuper Management Pty Ltd, Jennison Associates LLC, BAM Wealth Management LLC and others have increased their stakes while while Dash Acquisitions Inc., Resona Asset Management Co. Ltd. among a few others have decreased their stakes. The company has seen a decent 30% return over the last five years satisfying its investors. Earnings are expected to grow, reflected through a positive financial outlook. Leadership changes and a strategic implementation of artificial intelligence could reshape its investment attractivity. Moreover, a new collaboration with NVIDIA to bring advanced AI to lab workflows has potential to revolutionize the industry. The stock price has recently dipped but analysts suggest, based on historical performance, that potential price resurgence could be in the pipeline. The firm has made significant moves in bioprocessing and cardio testing and recently announced a strategic collaboration with NVIDIA. Expectations are high with Morgan Stanley being bullish on Thermo Fisher. Acquisition of Clario Holdings, Inc. and authorisation of $5 Billion of Share Repurchases could enhance its market position and investor confidence.
Thermo Fisher Scientific TMO News Analytics from Thu, 08 May 2025 07:00:00 GMT to Sat, 24 Jan 2026 21:31:39 GMT - Rating 7 - Innovation 6 - Information 8 - Rumor 1
